Chemoinformaics analysis of 1BETA-ACETOXYFURANO-3-EUDESMENE
| Molecular Weight | 276.376 | nRot | 1 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 16 |
| Exact Molecular Weight | 276.173 | nRing | 3 |
| Solubility: LogS | -3.951 | nHRing | 1 |
| Solubility: LogP | 3.486 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 46.799 |
| nHD | 0 | BPOL | 28.417 |
| QED | 0.542 |
| Synth | 4.682 |
| Natural Product Likeliness | 3.006 |
| NR-PPAR-gamma | 0.026 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.007 |
| HIA | 0.012 |
| CACO-2 | -4.525 |
| MDCK | 0.0000118 |
| BBB | 0.974 |
| PPB | 0.749043 |
| VDSS | 1.521 |
| FU | 0.301973 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.093 |
| CYP2c19-inh | 0.069 |
| CYP2c19-sub | 0.811 |
| CYP2c9-inh | 0.09 |
| CYP2c9-sub | 0.24 |
| CYP2d6-inh | 0.041 |
| CYP2d6-sub | 0.504 |
| CYP3a4-inh | 0.601 |
| CYP3a4-sub | 0.508 |
| CL | 6.429 |
| T12 | 0.207 |
| hERG | 0.033 |
| Ames | 0.051 |
| ROA | 0.07 |
| SkinSen | 0.184 |
| Carcinogencity | 0.951 |
| EI | 0.04 |
| Respiratory | 0.617 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.643578 |